Azithromycin 200mg/5mL Powder for Oral Suspension 22.5mL [PRESCRIPTION REQUIRED]

REMINDER: A doctor&rsquo,s prescription is required to purchase this product. To avoid delay in delivery or cancellation of your order ,(before the item is SHIPPED), please email a copy of your prescription (.jpeg or .pdf file format) to ,OnlinePharmacy@watsons.com.ph ,with your order number after Checkout. Our pharmacist will also get in touch with you to validate your prescription. Please be ready to show your original prescription upon claiming/delivery of your order.

 ,

 ,

 ,

For the treatment of infections caused by susceptible organisms in upper resp (including sinusitis &, pharyngitis/tonsilitis) &, lower resp (including bronchitis &, pneumonia) tract, skin &, soft tissue infections, acute otitis media. Uncomplicated genital infections due to Chlamydia trachomatis, chancroid due to Haemophilus ducreyi &, uncomplicated genital infection due to non-multiresistant Neisseria gonorrhoea, concurrent infection with Treponema pallidum should be excluded. Alone or in combination with rifabutin for prophylaxis against Mycobacterium avium intracellulare complex (MAC) infection. In combination with ethambutol for the treatment of disseminated MAC (DMAC) infection in patients with advanced HIV infection. Inj: Community acquired pneumonia (CAP) caused by Legionella pneumophila &, pelvic inflammatory diseases (PID) caused by Chlamydia trachomatis, Neisseria gonorrhoea, Mycoplasma hominis) in patients who require initial IV therapy.

Place of Origin

Italy

Product Usage

May be taken w/ meals to reduce GI discomfort.

Ingredients

Each 5 mL of powder for oral suspension; when reconstituted as directed; contains Azithromycin Dihydrate equivalent to Azithromycin 200 mg.

Storage Information

Store at temperatures not exceeding 25°C for the powder and the reconstituted solution.

Warnings

Serious allergic reactions (angioedema & anaphylaxis); dermatologic reactions (Stevens-Johnson syndrome & toxic epidermal necrolysis) & drug reaction with eosinophilia & systemic symptoms; abnormal liver function; hepatitis; cholestatic jaundice; hepatic necrosis & failure. Clostridium difficile-associated diarrhea. Prolonged cardiac repolarization & QT interval; imparting a risk of developing cardiac arrhythmia & torsades de pointes. Risk of QT prolongation for patients with congenital or documented QT prolongation; electrolyte disturbance; particularly in cases of hypokalaemia & hypomagnesemia; clinically relevant bradycardia; cardiac arrhythmia/insufficiency; significant hepatic disease; receiving drugs known to prolong QT interval eg; antiarrhythmics class IA/III; antipsychotics; antidepressants & fluoroquinolones. Concomitant use with ergot derivatives. Administer IV infusion over not <60 min. Elderly.

Width

1

Height

1

Depth

1